Notifications
Back
Notification settings
Back
More
Post notifications
Post reactions
Be notified when someone leaves a comment or a reply to your post or comment.
Updates and news
Stay ahead of important updates and news from the site.
Alarm
My account
Sign out
Sign-in required.
Sign in
About Us
Greetings
Our Vision
Our Platform
Our Partners
Pharmacometrics
What is M&S?
Methods
Benefits
Our Projects
Services
Early Phase Clinical Trials
Pharmacometric Analysis
News
Newsletter
K-BIO R&D News
Press Releases
Training & Workshops
Events
Contact Us
Our Location
Talk to Consultants
Matching Platform
Close
About Us
Company
Services
Process
Pharmacometrics
Modeling & Simulation
Our Projects
News
Newsletter
K-BIO R&D News
Press Releases
Training & Workshops
Events
Contact Us
Our Location
Talk to Consultants
About Us
Company
Services
Process
Pharmacometrics
Modeling & Simulation
Our Projects
News
Newsletter
K-BIO R&D News
Press Releases
Training & Workshops
Events
Contact Us
Our Location
Talk to Consultants
Check out our press releases, events,
and learning sessions!
Newsletter
K-BIO R&D News
Press Releases
Training & Workshops
Events
K
-BIO
R&
D
News
New post
Search
Updates and news
샤페론, 코로나19 치료제 임상 2b·3상 계획 승인 [2022.01.13]
0
0
20 Jan 2022
Views
330
Updates and news
이수앱지스, ErbB3 타깃 항암신약 ‘ISU104’ 유럽 특허 [2021.07.02]
0
0
5 Jul 2021
Views
509
Updates and news
대웅제약, 'PRS 저해제' IPF 호주1상 "안전성 확인" [2021.05.20]
0
0
21 May 2021
Views
568
Updates and news
식약처, 유틸렉스 면역항암제 임상1·2상 계획 승인 [2021.05.17]
0
0
21 May 2021
Views
495
Updates and news
GC녹십자, 차세대 혈우병치료제 연구논문 국제학술지 게재 [2021.05.20]
0
0
21 May 2021
Views
368
Updates and news
대원제약, 고지혈증 치료 신약 ‘DW-4301‘ 임상 2상 승인 [2021.04.26]
0
0
29 Apr 2021
Views
370
Updates and news
이수앱지스 애브서틴, 호주 비교 임상1상 완료 [2021.03.05]
0
0
5 Mar 2021
Views
438
Updates and news
미토이뮨, '미토콘드리아 신약' "美 2상 IND 승인" [2021.02.03]
0
0
3 Feb 2021
Views
601
Updates and news
NOV·유틸렉스, 면역항암제 후보물질 ‘EU101’ FDA 임상 1·2상 승인 [2021.01.27]
0
0
29 Jan 2021
Views
532
Previous
1
2
3
4
Next
